References

Barsby RW et al. Feverfew extracts and parthenolide irreversibly inhibit vascular responses of the rabbit aorta. J

Pharm Pharmacol 44.9 (1992): 737-40. Barsby RW, Knight DW, McFadzean I. A chloroform extract of the herb feverfew blocks voltage-dependent potassium currents recorded from single smooth muscle cells. J Pharm Pharmacol 45.7 (1993a): 641-5. Barsby RW et al. Feverfew and vascular smooth muscle: extracts from fresh and dried plants show opposing pharmacological profiles, dependent upon sesquiterpene lactone content. Planta Med 59.1 (1993b): 20-5. Biggs MJ et al. Platelet aggregation in patients using feverfew for migraine. Lancet 2.8301 (1982): 776. Brown AM et al. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro. J Pharm Pharmacol 49.5 (1997): 558-61.

Capasso F. The effect of an aqueous extract of Tanacetum parthenium L. on arachidonic acid metabolism by rat peritoneal leucocytes. J Pharm Pharmacol 38.1 (1986): 71-2. Collier HO et al. Extract of feverfew inhibits prostaglandin biosynthesis. Lancet 2.8200 (1980): 922-3. Cutlan ARet al. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin. Planta Med. 66.7 (2000): 612-17. Diener HC et al. Efficacy and safety of 6.25 mg t.i.d. feverfew C02-extract (MIG-99) in migraine prevention: a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 25(11) (2005): 1031-41. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr 3.4A (2000): 509-14. Ferrari MD. Migraine. Lancet 351.9108 (1998): 1043-51.

Finkey MB et al. Parthenolide-free feverfew extract protects the skin against UV damage and inflammation. J Am Acad Dermatol 52.3 (2005): 93.

Groenewegen WA, Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol 42.8 (1990): 553-7.

Hayes NA, Foreman JC. The activity of compounds extracted from feverfew on histamine release from rat mast cells. J Pharm Pharmacol 39.6 (1987): 466-70.

Heptinstall S. Feverfew: an ancient remedy for modern times? J R Soc Med 81.7 (1988): 373-4.

Heptinstall S et al. Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch 115.4 (1988): 447-9.

Jain NK, Kulkarni SK. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol 68.1-3 (1999): 251-9.

Johnson ES et al. Efficacy of feverfew as prophylactic treatment of migraine. BMJ (Clin Res Ed) 291.6495 (1985): 569-73.

Kwok BH et al. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol 8.8 (2001): 759-66.

Makheja AN, Bailey JM. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Prostaglandins Leukot Med 8.6 (1982): 653-60.

Maries RJ et al. A bioassay for inhibition of serotonin release from bovine platelets. J Nat Prod 55.8 (1992): 1044-56.

Martin K et al. Pathenolide-free feverfew: an extract with effective anti-irritant activity in vitro. J Am Acad Dermatol 52.3 (2005): 93.

Mendonca MS et al. Inhibition of constitutive NF [kappa] B activity by the anti-inflammatory sesquiterpene, parthenolide slows cell growth and increases radiation sensitivity. Int J Radiat Oncol Biol Physics 57.2 (Suppl 1) (2003): S354.

Mittra S, Datta A, Singh SK, Singh A. 5-hydroxytryptamine-inhibiting property of feverfew: role of parthenolide content. Acta Pharmacol Sin; 21(12) (2000): 1106-14.

Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 2.8604 (1988): 189-92.

Pattrick M, Heptinstall S, Doherty M. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis 48.7 (1989): 547-9.

Pittler M, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev 1 (2004): CD 002286.

Pugh WJ, Sambo K. Prostaglandin synthetase inhibitors in feverfew. J Pharm Pharmacol 40.10 (1988): 743-5.

Silberstein SD. Migraine. Lancet 363.9406 (2004): 381-91.

Smolinski AT, Pestka JJ. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rbl (ginseng) and parthenolide (feverfew). Food Chem Toxicol 41.10 (2003): 1381-90.

Tournier H et al. Effect of the chloroform extract of Tanacetum vulgare and one of its active principles, parthenolide, on experimental gastric ulcer in rats. J Pharm Pharmacol 51.2 (1999): 215-19.

Weber JT et al. Rabbit cerebral cortex 5HTla receptors. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 117.1 (1997a): 19-24.

Weber JT et al. Activity of Parthenolide at 5HT2A receptors. J Nat Prod 60.6 (1997b): 651-3.

Wong HR, Menendez IY. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 262.2 (1999): 375-80.

Was this article helpful?

0 0
Arthritis Relief and Prevention

Arthritis Relief and Prevention

This report may be oh so welcome especially if theres no doctor in the house Take Charge of Your Arthritis Now in less than 5-Minutes the time it takes to make an appointment with your healthcare provider Could you use some help understanding arthritis Maybe a little gentle, bedside manner in your battle for joint pain relief would be great Well, even if you are not sure if arthritis is the issue with you or your friend or loved one.

Get My Free Ebook


Post a comment